Streetbeat News

Stock Prices

ENPH

Wells Fargo analyst Praneeth Satish has upgraded Enphase Energy (NASDAQ:ENPH) from Equal-Weight to Overweight and increased the price target from $98 to $141, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 11:08 am

DELL

JP Morgan analyst Samik Chatterjee has upgraded Dell Technologies (NYSE:DELL) from Neutral to Overweight and increased the price target from $77 to $90.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 11:07 am

TOL

Wolfe Research analyst Truman Patterson upgraded Toll Brothers (NYSE:TOL) from Peer Perform to Outperform and set a price target of $118.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 11:06 am

ICE

Barclays analyst Benjamin Budish upgraded Intercontinental Exchange (NYSE:ICE) from Equal-Weight to Overweight and increased the price target from $120 to $148.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 11:05 am

AMGN

BMY

MRNA

SRPT

VRTX

XBI

The 42nd annual JPMorgan Healthcare Conference begins in San Francisco, with expectations of significant industry discussions, potential deal announcements, and company presentations. Past conferences have influenced M&A activity and stock volatility. Bristol-Myers Squibb, Vertex Pharmaceuticals, Amgen, Sarepta Therapeutics, and Moderna are among the companies presenting. The SPDR S&P Biotech ETF (XBI) has shown varied performance during past conferences, with individual stocks potentially experiencing volatility based on news from the event.

Portfolio Pulse from Shanthi Rexaline

January 08, 2024 | 11:04 am

CBOE

Barclays analyst Benjamin Budish upgraded Cboe Global Markets (CBOE) from Equal-Weight to Overweight and increased the price target from $189 to $204.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 11:02 am

VZIO

Needham analyst Laura Martin has maintained a Buy rating on VIZIO Holding (NYSE:VZIO) and increased the price target from $8 to $9.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 10:42 am

ALT

ANNX

BETR

CRON

HARP

HRTX

NXT

SABR

UPWK

In Monday's pre-market session, Harpoon Therapeutics, Inc. (HARP) shares surged 98.6% after reports of Merck's advanced talks to acquire the company at $23 per share. Other stocks showing pre-market gains include Heron Therapeutics, Inc. (HRTX), which announced a distribution partnership, and several others like Better Home & Finance Holding Company (BETR), Sabre Corporation (SABR), Cronos Group Inc. (CRON), Nextracker Inc. (NXT), Upwork Inc. (UPWK), Altimmune, Inc. (ALT), and Annexon, Inc. (ANNX) due to various factors.

Portfolio Pulse from Avi Kapoor

January 08, 2024 | 10:37 am

ADXN

Addex Therapeutics is experiencing a premarket increase on low volume. The company is scheduled to present at the Biotech Showcase on Monday.

Portfolio Pulse from Charles Gross

January 08, 2024 | 10:32 am

NVDA

Nvidia is set to launch an AI chip specifically designed for the Chinese market in the second quarter of 2024, according to sources familiar with the matter. This move comes as a strategic step to navigate the complex trade restrictions and maintain its presence in the critical Chinese market.

Portfolio Pulse from Charles Gross

January 08, 2024 | 10:22 am